Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Prospective Randomized Trial Assessing the Safety and Effectiveness of the DurAVR® Biomimetic Valve Designed for Physiologic Flow Compared to Commercial TAVR Devices

NCT07194265 is registered in ClinicalTrials.gov with Anteris Technologies Ltd. as lead sponsor.

NCT NCT07194265
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07194265 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Prospective Randomized Trial Assessing the Safety and Effectiveness of the DurAVR® Biomimetic Valve Designed for Physiologic Flow Compared to Commercial TAVR Devices
Lead sponsor
Anteris Technologies Ltd.
Phase
Not applicable
Overall status
Recruiting
Start date
October 21, 2025
Completion date
March 31, 2038
Enrollment
1,650 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

severe aortic stenosis, valve-in-valve procedures